U.S. Physical Therapy Returned Its Guidance For Adjusted EBITDA For 2024 To Its Original Range Of $80M-$85M
Portfolio Pulse from Benzinga Newsdesk
U.S. Physical Therapy has revised its guidance for adjusted EBITDA for 2024 back to its original range of $80 million to $85 million.
August 13, 2024 | 8:33 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
U.S. Physical Therapy has revised its guidance for adjusted EBITDA for 2024 back to its original range of $80 million to $85 million.
The return to the original EBITDA guidance range suggests stability and confidence in the company's financial outlook, which is likely to positively impact investor sentiment and the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100